Utilisation of medical services in Germany and Europe - Results of the European Health Interview Survey (EHIS 3, 2018 - 2020)

J Health Monit. 2024 Nov 27;9(4):e12921. doi: 10.25646/12921. eCollection 2024 Dec.

Abstract

Background: Needs-based care is a central concern of healthcare policy. A European comparison of the utilisation of medical services can help to assess national data and identify the need for action.

Methods: This article describes indicators on the utilisation of outpatient and inpatient services, medical examinations and the use of medicines from the third wave of the European Health Interview Survey (EHIS 3) and compares the results from Germany with the European averages.

Results: Age-standardised, the utilisation of medical services in Germany was above the European average without exception, whereby demographic and social differences were similar. Almost all services were utilised more frequently by women and in older age groups. Exceptions are inpatient services and colonoscopy, where there was no difference between the sexes, and more frequent use of psychiatric and psychotherapeutic services and non-prescription medication among younger adults. Specialist medical and dental services were used more frequently in the high education group, psychiatric and psychotherapeutic services as well as inpatient services and prescription medication in the low education group.

Conclusions: The European comparison requires a differentiated categorisation of the findings. While the high utilisation in Germany for some evidence-based services (e.g. colonoscopy, dentistry) indicates good access to care, the high inpatient utilisation, for example, is also the subject of critical discussion.

Keywords: Demographics; Dentistry; Early detection of cancer; European Health Interview Survey; Hospital; Medication; Outpatient care; Psychiatry; Psychotherapy; Utilisation.

Grants and funding

The countries participating in EHIS are committed to carry out and finance the national sub-studies. GEDA 2019/2020-EHIS was funded by the Robert Koch Institute and the Federal Ministry of Health. Information on the funding of further sub-studies can be found in the documentation and publications of the participating countries. The present analysis was supported by funding from the Federal Ministry of Health as part of the project National Diabetes Surveillance with Extension to NCD Surveillance (funding code: 2523DIA002).